TY  - JOUR
AU  - Guerrero-Orriach, Jose L
AU  - Malo-Manso, Alfredo
AU  - Ramirez-Aliaga, Marta
AU  - Florez Vela, Ana Isabel
AU  - Galán-Ortega, Manuel
AU  - Moreno-Cortes, Isabel
AU  - Gonzalez-Almendros, Inmaculada
AU  - Ramirez-Fernandez, Alicia
AU  - Ariza-Villanueva, Daniel
AU  - Escalona-Belmonte, Juan Jose
AU  - Quesada-Muñoz, Guillermo
AU  - Sepúlveda-Haro, Enrique
AU  - Romero-Molina, Salvador
AU  - Bellido-Estevez, Inmaculada
AU  - Gomez-Luque, Aurelio
AU  - Rubio-Navarro, Manuel
AU  - Alcaide-Torres, Juan
AU  - Santiago-Fernandez, Concepcion
AU  - Garrido-Sanchez, Lourdes
AU  - Cruz-Mañas, Jose
PY  - 2020
DO  - 10.3389/fphar.2020.01331
SN  - 1663-9812
UR  - http://hdl.handle.net/10668/16327
T2  - Frontiers in pharmacology
AB  - Low-cardiac output syndrome (LCOS) after cardiac surgery secondary to systemic hypoperfusion is associated with a higher incidence of renal and neurological damage. A range of effective therapies are available for LCOS. The beneficial systemic effects...
LA  - en
KW  - cardiac surgery
KW  - dobutamine
KW  - kidney
KW  - levosimendan
KW  - low cardiac output
TI  - Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01.
TY  - research article
VL  - 11
ER  -